Abeona Therapeutics Inc

(NASDAQ:ABEO)

Latest On Abeona Therapeutics Inc (ABEO):

Date/Time Type Description Signal Details
2023-05-25 03:16 ESTNewsAbeona Therapeutics Inc. (ABEO) Q1 2023 Earnings Call TranscriptN/A
2023-05-24 13:01 ESTNewsAbeona Therapeutics Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-23 23:01 ESTNewsAbeona Therapeutics Q1 2023 Earnings PreviewN/A
2023-05-11 16:03 ESTNewsAbeona stock rises on new data for rare skin disorder drug EB-101N/A
2023-05-11 16:03 ESTNewsAbeona Therapeutics GAAP EPS of -$0.54 beats by $0.07N/A
2023-04-26 14:31 ESTNewsAbeona: BLA Submission Of EB-101 Gets The Ball RollingN/A
2023-03-29 08:30 ESTNewsAbeona Therapeutics GAAP EPS of -$5.53 misses by $1.61, revenue of $1.41M misses by $0.91MN/A
2022-12-02 00:46 ESTNewsAbeona Therapeutics files for offering of 15.2M shares by sellersN/A
2022-11-14 21:47 ESTNewsAbeona Therapeutics GAAP EPS of -$1.48N/A
2022-11-03 22:32 ESTNewsAbeona Therapeutics announces $35M private placementN/A
2022-11-03 22:32 ESTNewsAbeona says phase 3 trial of EB-101 cell therapy for rare skin disorder meets main goalsN/A
2022-10-19 21:33 ESTNewsAbeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder ValueN/A
2022-10-04 12:30 ESTNewsAbeona Therapeutics stock continues recent strong run, shares rise ~10%N/A
2022-10-03 22:01 ESTNewsCantor lists three “high conviction” Phase 3 biotech readouts for Q4N/A
2022-08-18 06:31 ESTNewsAbeona Therapeutics (ABEO) Investor Presentation - SlideshowN/A
2022-08-11 22:16 ESTNewsAbeona Therapeutics GAAP EPS of -$2.08, revenue of $1MN/A
2022-07-20 18:02 ESTNewsAbeona therapeutics regains compliance with Nasdaq minimum bid price requirementN/A
2022-07-06 02:02 ESTNewsAbeona crashes 21% as reverse stock split takes effectN/A
2022-05-19 16:17 ESTNewsAbeona Therapeutics gets additional 180-day to regain Nasdaq complianceN/A
2022-05-18 20:48 ESTNewsAbeona Therapeutics Inc.'s (ABEO) CEO Vishwas Seshadri on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-18 02:17 ESTNewsUltragenyx to buy global rights to Abeona's gene therapy ABO-102 for fatal brain condition in kidsN/A
2022-05-18 02:16 ESTNewsAbeona Therapeutics (ABEO) CEO, Vishwas Seshadri on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 09:47 ESTNewsAbeona Therapeutics GAAP EPS of -$0.14 misses by $0.04, revenue of $0.35MN/A
2022-04-29 19:47 ESTNewsAbeona Therapeutics tp raise $25M in convertible preferred stock offeringN/A
2022-04-01 02:02 ESTNewsAbeona Therapeutics GAAP EPS of -$0.45 beats by $0.15, revenue of $3MN/A
2022-03-14 23:01 ESTNewsAbeona reaches enrollment target in phase 3 trial of EB-101 for rare skin wound disorderN/A
2022-03-10 11:31 ESTNewsAbeona adds new CFO from Avenue TherapeuticsN/A
2021-12-16 21:47 ESTNewsAbeona Therapeutics plunges 18% on stock offeringN/A
2021-11-15 19:48 ESTNewsAbeona Therapeutics EPS beats by $0.09N/A
2021-11-02 11:16 ESTNewsWarning: ABEO is at high risk of performing badlyN/A
2021-10-06 00:47 ESTNewsAbeona sinks to a 52-week low as CEO sells sharesN/A
2021-09-22 20:39 ESTNewsAbeona Therapeutics EPS beats by $0.01N/A
2021-08-10 19:34 ESTNewsAbeona Therapeutics appoints new chief financial officerN/A
2021-07-28 17:04 ESTNewsAbeona completes Type B meeting with FDA for ABO-102 in Sanfilippo syndrome type AN/A
2021-07-26 11:47 ESTNewsAbeona soars 11% after ABO-102 increases brain volume in Sanfilippo Syndrome Type A patientsN/A
2021-07-23 14:17 ESTNewsAbeona activates second site in EB-101 late-stage connective tissue disorder studyN/A
2021-07-20 18:03 ESTNewsAbeona Therapeutics Inc. (ABEO) CEO Michael Amoroso on Q1 2021 Results - Earnings Call TranscriptN/A
2021-07-20 18:03 ESTNewsAbeona Therapeutics shares rise after letter to stockholdersN/A
2021-07-20 17:31 ESTNewsAbeona Therapeutics reports updated EB-101 data in recessive dystrophic epidermolysis bullosaN/A
2021-07-20 17:24 ESTNewsREGENXBIO and Abeona update on arbitration of licensing disputeN/A
2021-03-26 04:01 ESTNewsAbeona Therapeutics Inc. (ABEO) CEO Michael Amoroso on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-25 08:32 ESTNewsAbeona Therapeutics EPS misses by $0.07, misses on revenueN/A
2021-03-22 21:49 ESTNewsAbeona Therapeutics appoints Michael Amoroso as CEON/A
2021-03-11 02:01 ESTNewsAbeona Therapeutics: Undervalued And Nearing An UpswingN/A
2021-03-11 02:01 ESTNewsThe Right Play On Abeona TherapeuticsN/A
2021-02-23 03:00 ESTAnalyst RatingThe Analyst Target Price has increased from $5 to $5.67.Buy
2021-02-12 13:46 ESTNewsAbeona posts data from two early-stage rare lysosomal storage disease studiesN/A
2021-02-09 09:00 ESTNewsTLRY, GLUU, ABEO and TYME among premarket gainersN/A
2021-01-25 12:32 ESTNewsAbeona Therapeutics on go with the enrollment of patients with epidermolysis bullosaN/A
2021-01-18 18:46 ESTNewsAbeona: Close To Confirming A Long-Term BottomN/A

About Abeona Therapeutics Inc (ABEO):

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

ABEO Quotes by TradingView

See Advanced Chart

General

  • Name Abeona Therapeutics Inc
  • Symbol ABEO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 88
  • Last Split Factor1:50
  • Last Split Date2014-10-24
  • Fiscal Year EndDecember
  • IPO Date1980-09-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.abeonatherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 27.89
  • Price/Book (Most Recent Quarter) 1.93
  • Enterprise Value Revenue 19.17
  • Enterprise Value EBITDA 0.13
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Operating Margin -721%
  • Return on Assets -21%
  • Return on Equity -80%
  • Revenue 7 million
  • Earnings Per Share -$1.59
  • Revenue Per Share $0.08
  • Gross Profit -48566000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 205.72 million
  • EBITDA -72345000
  • Analyst Target Price $5.67
  • Book Value Per Share $1.36
View More

Share Statistics

  • Shares Outstanding 96.13 million
  • Shares Float 75.7 million
  • % Held by Insiders 1622%
  • % Held by Institutions 37.93%
  • Shares Short 3.41 million
  • Shares Short Prior Month 2.95 million
  • Short Ratio 0.48
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.56
  • 52 Week High $3.79
  • 52 Week Low $0.99
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 1.78
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Abeona Therapeutics Inc (ABEO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Abeona Therapeutics Inc (ABEO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$N/A-$0.08-$0.1338.46%
2020-06-302020-08-10$N/A-$0.14-$0.1717.65%
2020-03-312020-05-06$N/A-$0.52-$0.24-112.85%
2019-12-312020-03-16$N/A-$0.30-$0.313.66%
2019-09-302019-11-12$N/A-$0.35-$0.4115.46%
2019-06-302019-08-09$N/A-$0.49-$0.37-33.99%
2019-03-312019-05-10$N/A-$0.39-$0.31-27.87%
2018-12-312019-03-18$-2128000-$0.42-$0.41-2.09%
2018-09-302018-11-09$1.71 million-$0.34-$0.26-32.97%
2018-06-302018-08-09$819000-$0.25-$0.19-31.58%
2018-03-312018-05-10$2.6 million-$0.18-$0.193.23%
2017-12-312018-03-16$215000-$0.19-$0.14-37.68%
2017-09-302017-11-14$219000-$0.13-$0.1829.08%
2017-06-302017-08-14$217000-$0.21-$0.14-50%
2017-03-312017-05-15$186000-$0.13-$0.1618.75%
2016-12-312017-03-30$256000-$0.19-$0.15-24.59%
2016-09-302016-11-10$184000-$0.08-$0.1856.36%
2016-06-302016-08-15$214000-$0.20-$0.16-29.03%
2016-03-312016-05-16$235000-$0.17-$0.14-25.93%
2015-12-312016-03-08$215000-$0.07-$0.1136.36%
2015-09-302015-11-17$285000-$0.19-$0.11-72.73%
2015-06-302015-08-14$282000-$0.16-$0.09-77.78%
2015-03-312015-05-14$258000-$0.10
2014-09-302014-11-14$236000-$4.15
2014-06-302014-08-14$247000-$25.26
2014-03-312014-06-13$208000-$3.06
2013-12-312014-03-27$162000-$3.50
2013-09-302013-11-15$189000-$1.77
2013-06-302013-08-14$467000$1.70
2013-03-312013-05-16$1.22 million$6.67
2012-12-312013-03-20$1.01 million$39.50
2012-09-302012-11-15$871000-$31.67
2012-06-302012-08-15$690000-$22.85
2012-03-312012-05-15$1.84 million-$2.50$3.50-171.43%
2011-12-312012-03-23$498000-$6.00-$1.50-300%
2011-09-302011-11-14$1.04 million-$0.25
2011-06-302011-08-15$150000-$4.40
2011-03-312011-05-16$150000-$7.00-$7.506.67%
2010-12-312011-03-31$147000-$10.00-$10.000%
2010-09-302010-11-12$127000-$9.00-$5.50-63.64%
2010-06-302010-08-16$105000-$3.50-$5.5036.36%
2010-03-312010-05-17$102000$3.07
2009-12-312010-03-22$104000-$39.00-$10.00-290%
2009-09-302009-11-16$144000-$18.50-$11.50-60.87%
2009-06-302009-08-14$63000-$11.80
2009-03-312009-05-19$41000-$12.24
2008-12-312009-03-31$74000-$15.50-$28.5045.61%
2008-09-302008-11-17$47000-$28.68
2008-06-302008-08-14$132000-$24.50-$22.00-11.36%
2008-03-312008-05-20$38000-$115.50
2007-09-302007-11-19$6000-$27.37
2007-06-302007-08-14$N/A-$29.80
2007-03-312007-05-15$N/A-$58.37
2006-09-302006-11-20$N/A-$28.51
2006-06-302006-08-21$N/A-$47.17
2006-03-312006-06-16$N/A-$68.80
2005-09-302005-11-17$N/A-$32.55
2005-06-302005-08-11$N/A-$60.19
2005-03-312005-05-11$N/A-$39.00
2004-09-302004-11-16$185000-$39.24
2004-06-302004-08-13$68000-$41.31
2004-03-312004-05-17$20000-$41.39
2003-12-312004-03-25$208000-$49.29
2003-09-302003-11-14$11000-$41.51
2003-06-302003-08-12$683000$4.17
2003-03-312003-05-15$393000-$45.66
2002-09-302002-11-12$91000-$54.29
2002-06-302002-08-15$263000-$45.00-$37.50-20%
2002-03-312002-05-16$116000-$36.07
2001-12-312002-03-28$11000-$30.00-$35.0014.29%
2001-09-302001-09-30$11000-$33.90
2001-06-302001-06-30$10000-$29.50
2001-03-312001-03-31$211000-$22.79
2000-09-302000-09-30$N/A-$26.99
2000-06-302000-06-30$N/A-$31.49
2000-03-312000-03-31$N/A-$34.82
1999-09-301999-09-30-$32.50
1999-06-301999-06-30-$64.73
1999-03-311999-03-31-$58.25
1998-09-301998-09-30-$61.25
1998-06-301998-06-30-$104.65
1998-03-311998-03-31-$6.89

Abeona Therapeutics Inc (ABEO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Abeona Therapeutics Inc (ABEO) Chart:

Abeona Therapeutics Inc (ABEO) News:

Below you will find a list of latest news for Abeona Therapeutics Inc (ABEO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Abeona Therapeutics Inc (ABEO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-212.53.6CALL0 76864.34TRUE00
2025-03-2151.13CALL0 129348.22TRUE00
2025-03-217.50.18CALL0 147111.66FALSE00
2025-03-21100.17CALL0 170149.14FALSE00
2025-03-212.50PUT0 00FALSE00
2025-03-2150.25PUT0 61489.24FALSE00
2025-03-217.52.55PUT0 2266.07TRUE00
2025-03-21100PUT0 0255.65TRUE00
2025-04-172.50CALL0 0433.19TRUE00
2025-04-1750CALL0 0118.82TRUE00
2025-04-177.50CALL0 0250.08FALSE00
2025-04-17100CALL0 0131.94FALSE00
2025-04-172.50PUT0 0634.48FALSE00
2025-04-1750PUT0 0219.65FALSE00
2025-04-177.50PUT0 0109.2TRUE00
2025-04-17100PUT0 0127.11TRUE00
2025-06-202.50CALL0 0147.51TRUE00
2025-06-2052CALL54 672126.05TRUE00
2025-06-207.50.99CALL2 648112.24FALSE0.990
2025-06-20100.6CALL0 68110.14FALSE00
2025-06-2012.50.28CALL1 38108.19FALSE0.280
2025-06-202.50.35PUT0 1263FALSE00
2025-06-2051PUT0 129111.42FALSE00
2025-06-207.52.79PUT0 2159.1TRUE00
2025-06-20100PUT0 0105.62TRUE00
2025-06-2012.57.19PUT0 1134.07TRUE00
2025-09-192.53.5CALL0 1138.33TRUE00
2025-09-1952CALL0 1131.59TRUE00
2025-09-197.51.15CALL0 124200.52FALSE00
2025-09-19101.1CALL0 1678.92FALSE00
2025-09-192.50PUT0 0294.98FALSE00
2025-09-1950PUT0 0166.89FALSE00
2025-09-197.50PUT0 092.58TRUE00
2025-09-19104.9PUT0 3086.8TRUE00

Latest ABEO Trades:

Date Shares Price
Jun 13, 2022 2:21 PM EST3$0.158
Jun 13, 2022 2:22 PM EST10$0.1555
Jun 13, 2022 2:22 PM EST100$0.1566
Jun 13, 2022 2:24 PM EST300$0.1566
Jun 13, 2022 6:15 PM EST30$0.1599

Abeona Therapeutics Inc (ABEO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220011653/0001493152-20-011653-index.htm
2019-08-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/318306/000000000019012029/0000000000-19-012029-index.htm
2019-09-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/318306/000000000019013704/0000000000-19-013704-index.htm
2019-09-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/318306/000000000019013872/0000000000-19-013872-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000008025519002416/0000080255-19-002416-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000008025520001035/0000080255-20-001035-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000031506619000844/0000315066-19-000844-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000031506619001597/0000315066-19-001597-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000031506619001700/0000315066-19-001700-index.htm
2018-05-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000031830618000003/0000318306-18-000003-index.htm
2018-05-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000031830618000004/0000318306-18-000004-index.htm
2018-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000031830618000005/0000318306-18-000005-index.htm
2018-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000031830618000006/0000318306-18-000006-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000090221919000084/0000902219-19-000084-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000090221920000304/0000902219-20-000304-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000090266419000916/0000902664-19-000916-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000090266420000948/0000902664-20-000948-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000090342319000016/0000903423-19-000016-index.htm
2020-04-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/318306/000091412120001562/0000914121-20-001562-index.htm
2019-09-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000093041319002491/0000930413-19-002491-index.htm
2019-12-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/318306/000093041319003101/0000930413-19-003101-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000110465919061110/0001104659-19-061110-index.htm
2019-12-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/318306/000110465919074456/0001104659-19-074456-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000110465919074462/0001104659-19-074462-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/318306/000110465919075672/0001104659-19-075672-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000110465919075690/0001104659-19-075690-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000110465919075843/0001104659-19-075843-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000110465919076304/0001104659-19-076304-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000110465920013396/0001104659-20-013396-index.htm
2020-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/318306/000114036120008572/0001140361-20-008572-index.htm
2020-04-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/318306/000114036120010109/0001140361-20-010109-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000114420418027209/0001144204-18-027209-index.htm
2018-05-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/318306/000114420418027637/0001144204-18-027637-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418027645/0001144204-18-027645-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418027650/0001144204-18-027650-index.htm
2018-05-148-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418028268/0001144204-18-028268-index.htm
2018-06-01S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/318306/000114420418032385/0001144204-18-032385-index.htm
2018-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/318306/000114420418032894/0001144204-18-032894-index.htm
2018-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418040790/0001144204-18-040790-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000114420418043278/0001144204-18-043278-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418043329/0001144204-18-043329-index.htm
2018-08-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418045185/0001144204-18-045185-index.htm
2018-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418045421/0001144204-18-045421-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418052561/0001144204-18-052561-index.htm
2018-10-098-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418053015/0001144204-18-053015-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418057433/0001144204-18-057433-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000114420418058739/0001144204-18-058739-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418058803/0001144204-18-058803-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418062416/0001144204-18-062416-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420418063355/0001144204-18-063355-index.htm
2019-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419001280/0001144204-19-001280-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419007291/0001144204-19-007291-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/318306/000114420419014623/0001144204-19-014623-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419014673/0001144204-19-014673-index.htm
2019-04-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019113/0001144204-19-019113-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019115/0001144204-19-019115-index.htm
2019-04-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019282/0001144204-19-019282-index.htm
2019-04-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019283/0001144204-19-019283-index.htm
2019-04-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019284/0001144204-19-019284-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019330/0001144204-19-019330-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019348/0001144204-19-019348-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019351/0001144204-19-019351-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019353/0001144204-19-019353-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019356/0001144204-19-019356-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019359/0001144204-19-019359-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419019439/0001144204-19-019439-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419020315/0001144204-19-020315-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419020316/0001144204-19-020316-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419020317/0001144204-19-020317-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419020318/0001144204-19-020318-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000114420419025271/0001144204-19-025271-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419025280/0001144204-19-025280-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419027766/0001144204-19-027766-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419028025/0001144204-19-028025-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419028027/0001144204-19-028027-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419028029/0001144204-19-028029-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419028030/0001144204-19-028030-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419028043/0001144204-19-028043-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419028638/0001144204-19-028638-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419035879/0001144204-19-035879-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419035881/0001144204-19-035881-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000114420419038872/0001144204-19-038872-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419038892/0001144204-19-038892-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419040069/0001144204-19-040069-index.htm
2019-08-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/318306/000114420419040824/0001144204-19-040824-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419043407/0001144204-19-043407-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000114420419044759/0001144204-19-044759-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419044839/0001144204-19-044839-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419045047/0001144204-19-045047-index.htm
2019-09-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/318306/000114420419045474/0001144204-19-045474-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000114420419045554/0001144204-19-045554-index.htm
2020-07-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000117266120001460/0001172661-20-001460-index.htm
2019-07-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000131924419000059/0001319244-19-000059-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/318306/000131924420000037/0001319244-20-000037-index.htm
2019-12-2025-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/318306/000135445719000674/0001354457-19-000674-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000149315219016905/0001493152-19-016905-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315219016924/0001493152-19-016924-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315219018983/0001493152-19-018983-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315219019948/0001493152-19-019948-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220000323/0001493152-20-000323-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220000364/0001493152-20-000364-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/318306/000149315220004015/0001493152-20-004015-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220004018/0001493152-20-004018-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220004028/0001493152-20-004028-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220004252/0001493152-20-004252-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220004254/0001493152-20-004254-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220004255/0001493152-20-004255-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220004256/0001493152-20-004256-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220004438/0001493152-20-004438-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220005895/0001493152-20-005895-index.htm
2020-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220006668/0001493152-20-006668-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220006669/0001493152-20-006669-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220006766/0001493152-20-006766-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220006853/0001493152-20-006853-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/318306/000149315220007004/0001493152-20-007004-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220007070/0001493152-20-007070-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000149315220007824/0001493152-20-007824-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220007832/0001493152-20-007832-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220009632/0001493152-20-009632-index.htm
2020-05-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009633/0001493152-20-009633-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009756/0001493152-20-009756-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009758/0001493152-20-009758-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009760/0001493152-20-009760-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009762/0001493152-20-009762-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009764/0001493152-20-009764-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009766/0001493152-20-009766-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009768/0001493152-20-009768-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220009770/0001493152-20-009770-index.htm
2020-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220011505/0001493152-20-011505-index.htm
2020-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220011507/0001493152-20-011507-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220011508/0001493152-20-011508-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220011509/0001493152-20-011509-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220011653/0001493152-20-011653-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/318306/000149315220015077/0001493152-20-015077-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220015098/0001493152-20-015098-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220016305/0001493152-20-016305-index.htm
2020-08-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/318306/000149315220016512/0001493152-20-016512-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220017788/0001493152-20-017788-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220017946/0001493152-20-017946-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220017963/0001493152-20-017963-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220018550/0001493152-20-018550-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220019030/0001493152-20-019030-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220019384/0001493152-20-019384-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220019385/0001493152-20-019385-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220019386/0001493152-20-019386-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220019566/0001493152-20-019566-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/318306/000149315220020221/0001493152-20-020221-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220020708/0001493152-20-020708-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000149315220020709/0001493152-20-020709-index.htm
2018-08-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/318306/000157104918000444/0001571049-18-000444-index.htm
2020-11-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000164117220000026/0001641172-20-000026-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/318306/000164117220000031/0001641172-20-000031-index.htm
2018-06-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/318306/999999999518001443/9999999995-18-001443-index.htm
2019-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/318306/999999999719002261/9999999997-19-002261-index.htm
2020-03-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/318306/999999999720000555/9999999997-20-000555-index.htm
2020-02-18SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/318306/999999999720000759/9999999997-20-000759-index.htm

Abeona Therapeutics Inc (ABEO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Abeona Therapeutics Inc (ABEO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1622%
Institutional Ownership: 3793%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-20Joao MD SiffertChief Executive OfficerBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009762/0001493152-20-009762-index.htm
2020-10-08Todd WiderDirectorBuy813,008.001,005,977.00https://www.sec.gov/Archives/edgar/data/318306/000149315220019385/0001493152-20-019385-index.htm
2020-09-15SCO CAPITAL PARTNERS LLCDirectorSell1,989.002.003,981.3811,919,292.00https://www.sec.gov/Archives/edgar/data/318306/000149315220017963/0001493152-20-017963-index.htm
2020-09-11SCO CAPITAL PARTNERS LLCDirectorSell4,600.002.019,243.7011,921,281.00https://www.sec.gov/Archives/edgar/data/318306/000149315220017788/0001493152-20-017788-index.htm
2020-09-10SCO CAPITAL PARTNERS LLCDirectorSell73,411.002.08152,481.9911,925,881.00https://www.sec.gov/Archives/edgar/data/318306/000149315220017788/0001493152-20-017788-index.htm
2020-08-17SCO CAPITAL PARTNERS LLC10% Share HolderSell80,000.002.85228,312.0011,999,292.00https://www.sec.gov/Archives/edgar/data/318306/000149315220016305/0001493152-20-016305-index.htm
2020-03-19EDWARD CARRChief Accounting OfficerSell6,446.001.8111,667.2613,554.00https://www.sec.gov/Archives/edgar/data/318306/000149315220004438/0001493152-20-004438-index.htm
2020-05-20Todd WiderDirectorBuy17,969.00192,969.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009768/0001493152-20-009768-index.htm
2020-10-09EDWARD CARRChief Accounting OfficerBuy143,182.00196,736.00https://www.sec.gov/Archives/edgar/data/318306/000149315220019384/0001493152-20-019384-index.htm
2019-09-12EDWARD CARRChief Accounting OfficerBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/318306/000114420419044759/0001144204-19-044759-index.htm
2019-04-10Stefano BuonoDirectorBuy20,980.007.54158,271.0220,980.00https://www.sec.gov/Archives/edgar/data/318306/000114420419019439/0001144204-19-019439-index.htm
2019-12-24Stefano BuonoDirectorBuy200,000.002.50500,000.00270,000.00https://www.sec.gov/Archives/edgar/data/318306/000149315219019948/0001493152-19-019948-index.htm
2020-05-20Stefano BuonoDirectorBuy17,969.00287,969.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009756/0001493152-20-009756-index.htm
2020-05-20Shawn TomaselloDirectorBuy35,938.0035,938.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009770/0001493152-20-009770-index.htm
2020-06-17GEORGE V MIGAUSKYDirectorBuy37,954.0037,954.00https://www.sec.gov/Archives/edgar/data/318306/000149315220011509/0001493152-20-011509-index.htm
2020-06-17Paul Elliot MannDirectorBuy37,954.0037,954.00https://www.sec.gov/Archives/edgar/data/318306/000149315220011508/0001493152-20-011508-index.htm
2012-01-23Stephen B. HowellDirectorBuy300.00495.00https://www.sec.gov/Archives/edgar/data/318306/000114420419027766/0001144204-19-027766-index.htm
2020-05-20Steven H RouhandehDirectorBuy120,000.00495,000.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009764/0001493152-20-009764-index.htm
2020-05-20EDWARD CARRChief Accounting OfficerBuy40,000.0053,554.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009758/0001493152-20-009758-index.htm
2019-04-08Duyne Richard B VanDirectorBuy6,000.007.7146,260.006,000.00https://www.sec.gov/Archives/edgar/data/318306/000114420419020318/0001144204-19-020318-index.htm
2019-04-11Stefano BuonoDirectorBuy49,020.007.91387,978.5970,000.00https://www.sec.gov/Archives/edgar/data/318306/000114420419019439/0001144204-19-019439-index.htm
2015-05-11Stephen B. HowellDirectorBuy75,000.0075,495.00https://www.sec.gov/Archives/edgar/data/318306/000114420419027766/0001144204-19-027766-index.htm
2019-04-08Stephen B. HowellDirectorBuy4,000.007.7731,080.0079,494.00https://www.sec.gov/Archives/edgar/data/318306/000114420419019115/0001144204-19-019115-index.htm
2020-05-20Christine Berni SilversteinDirectorBuy80,000.0080,000.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009766/0001493152-20-009766-index.htm
2020-11-02Paul Elliot MannDirectorSell30,488.001.0431,588.62820,474.00https://www.sec.gov/Archives/edgar/data/318306/000149315220020708/0001493152-20-020708-index.htm
2020-10-08Paul Elliot MannDirectorBuy813,008.00850,962.00https://www.sec.gov/Archives/edgar/data/318306/000149315220019386/0001493152-20-019386-index.htm
2020-11-02Todd WiderDirectorSell33,876.001.0435,105.70972,101.00https://www.sec.gov/Archives/edgar/data/318306/000149315220020709/0001493152-20-020709-index.htm
2020-05-20Stephen B. HowellDirectorBuy17,969.0097,463.00https://www.sec.gov/Archives/edgar/data/318306/000149315220009760/0001493152-20-009760-index.htm